Safety results
hypoxemia, Respiratory adverse, hypotension, pain
ADVERSE EVENTS, RESPIRATORY DEPRESSION, AIRWAY OBSTRUCTION
Any adverse events (including the incidence of hypotension) occurred in 68 cases in the RT group, 91 cases in the propofol group, and 41 cases in the R+P group, with a significant difference in pairwise comparison, P<0.001. A total of 53 patients had injection pain in the P group, while 6 patients in the RT group, and 11 patients in the R+P group, with a significantly lower incidence of injection pain in the RT and R+P groups than in the P group, P<0.001, with no statistical difference between the RT and R+P groups. Respiratory adverse events (including hypoxemia, respiratory depression, and upper airway obstruction) were 17 cases in the RT group, 22 cases in the propofol group, and 7 cases in the R+P group, with significant differences between the RT and R+P groups, 